CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $806 | -34.5% | 24,716 | -29.4% | 0.00% | -50.0% |
Q1 2023 | $1,231 | -31.3% | 35,008 | -10.5% | 0.00% | 0.0% |
Q4 2022 | $1,792 | -99.9% | 39,128 | -23.5% | 0.00% | -50.0% |
Q3 2022 | $2,477,000 | -96.3% | 51,145 | -97.0% | 0.00% | -95.6% |
Q2 2022 | $66,770,000 | +101066.7% | 1,699,426 | +94575.5% | 0.09% | – |
Q1 2022 | $66,000 | +1550.0% | 1,795 | +1695.0% | 0.00% | – |
Q4 2021 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | -99.9% | 100 | -99.9% | 0.00% | -100.0% |
Q1 2021 | $2,662,000 | -10.6% | 114,478 | -20.2% | 0.00% | -25.0% |
Q4 2020 | $2,979,000 | -47.4% | 143,399 | -45.2% | 0.00% | -50.0% |
Q3 2020 | $5,661,000 | -10.9% | 261,514 | -3.0% | 0.01% | -20.0% |
Q2 2020 | $6,354,000 | – | 269,590 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |